Docetaxel and Carboplatin in Treating Patients With Recurrent Stage IVB Squamous Cell Carcinoma (Cancer) of the Cervix
Status:
Terminated
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as docetaxel and carboplatin, work in different
ways to stop tumor cells from dividing so they stop growing or die. Combining docetaxel with
carboplatin may kill more tumor cells.
PURPOSE: This phase I/II trial is studying the side effects and best dose of docetaxel when
given together with carboplatin and to see how well they work in treating patients with
recurrent stage IVB squamous cell carcinoma (cancer) of the cervix.
Phase:
Phase 1
Details
Lead Sponsor:
Comprehensive Cancer Center of Wake Forest University Wake Forest University Health Sciences